Clinical Trial Update: Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial of tofacitinib in adults with active ankylosing spondylitis; results were posted in June 2016. The study evaluated multiple dose leve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED | Results posted: 2016-06-10